Related references
Note: Only part of the references are listed.Biology and therapeutic potential of interleukin-10
Margarida Saraiva et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
Stephan Wilmes et al.
SCIENCE (2020)
Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial
Aung Naing et al.
LANCET ONCOLOGY (2019)
A strategy for the selection of monovalent antibodies that span protein dimer interfaces
Jamie B. Spangler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Immune regulation and cytotoxic T cell activation of IL-10 agonists-Preclinical and clinical experience
Martin Oft
SEMINARS IN IMMUNOLOGY (2019)
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity
Jonathan Martinez-Fabregas et al.
ELIFE (2019)
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells
Walid Warda et al.
CANCER RESEARCH (2019)
Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells
Bertram Bengsch et al.
IMMUNITY (2018)
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs
Christina M. Rollings et al.
SCIENCE SIGNALING (2018)
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs
Christina M. Rollings et al.
SCIENCE SIGNALING (2018)
The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis
Ana Cardoso et al.
FRONTIERS IN IMMUNOLOGY (2018)
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Aung Naing et al.
CANCER CELL (2018)
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
Juan L. Mendoza et al.
IMMUNITY (2017)
Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
W. K. Eddie Ip et al.
SCIENCE (2017)
Ligand-induced type II interleukin-4 receptor dimers are sustained by rapid re-association within plasma membrane microcompartments
David Richter et al.
NATURE COMMUNICATIONS (2017)
Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases
Suguru Shigemori et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease
Lei Zhu et al.
GASTROENTEROLOGY RESEARCH (2017)
The paradoxical role of IL-10 in immunity and cancer
Mark H. Mannino et al.
CANCER LETTERS (2015)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Suppression of antigen presentation by IL-10
Sharad K. Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
Ankit Saxena et al.
CYTOKINE (2015)
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling
Stephan Wilmes et al.
JOURNAL OF CELL BIOLOGY (2015)
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga et al.
SCIENCE SIGNALING (2015)
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
Ignacio Moraga et al.
SCIENCE SIGNALING (2015)
The activating effect of IFN-γ on monocytes/macrophages is regulated by the LIF-trophoblast-IL-10 axis via Stat1 inhibition and Stat3 activation
Angham Dallagi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
Shuai Zhao et al.
PLOS ONE (2015)
Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease
Natalie Frede et al.
BMC IMMUNOLOGY (2014)
Transcription Factor STAT3 and Type I Interferons Are Corepressive Insulators for Differentiation of Follicular Helper and T Helper 1 Cells
John P. Ray et al.
IMMUNITY (2014)
Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function
Dror S. Shouval et al.
IMMUNITY (2014)
IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
Martin Oft
CANCER IMMUNOLOGY RESEARCH (2014)
The Molecular Basis of IL-10 Function: from Receptor Structure to the Onset of Signaling
Mark R. Walter
INTERLEUKIN-10 IN HEALTH AND DISEASE (2014)
Pegylated IL-10 induces cancer immunity
John B. Mumm et al.
BIOESSAYS (2013)
IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without De Novo Infiltration from Secondary Lymphoid Organs
Jan Emmerich et al.
CANCER RESEARCH (2012)
IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
John B. Mumm et al.
CANCER CELL (2011)
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
Xiang-Ping Yang et al.
NATURE IMMUNOLOGY (2011)
Modulation of protein properties in living cells using nanobodies
Axel Kirchhofer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Recombinant human interleukin 10 for induction of remission in Crohn's disease
Felicia Elena Buruiana et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Defective IL-10 production in severe phenotypes of Crohn's disease
Ismael Correa et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system
Sherry L. LaPorte et al.
CELL (2008)
Dynamic multiple-target tracing to probe spatiotemporal cartography of cell membranes
Arnauld Serge et al.
NATURE METHODS (2008)
Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema
Mathieu C. Morissette et al.
RESPIRATORY RESEARCH (2007)
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling
PO Krutzik et al.
NATURE METHODS (2006)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Same structure, different function: Crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain
SI Yoon et al.
STRUCTURE (2005)
Reprogramming of IL-10 activity and signaling by IFN-γ1
C Herrero et al.
JOURNAL OF IMMUNOLOGY (2003)
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
NJ Logsdon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Mutational switch of an IL-6 response to an interferon-γ-like response
AP Costa-Pereira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
JF Colombel et al.
GUT (2001)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Design and analysis of an engineered human interleukin-10 monomer
K Josephson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)